EP4121434 - CRYSTALLINE FORMS OF SQUALAMINE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.12.2022 Database last updated on 13.07.2024 | |
Former | The international publication has been made Status updated on 24.09.2021 | Most recent event Tooltip | 23.03.2024 | Supplementary search report | published on 24.04.2024 [2024/17] | Applicant(s) | For all designated states Enterin, Inc. 2005 Market Street, Suite 3125 Philadelphia, Pennsylvania 19103 / US | [2023/04] | Inventor(s) | 01 /
KINNEY, William A. c/o Enterin, Inc. 2005 Market Street, Suite 3125 Philadelphia, Pennsylvania 19103 / US | 02 /
KUMAR, Anil c/o Enterin, Inc. 2005 Market Street, Suite 3125 Philadelphia, Pennsylvania 19103 / US | 03 /
GAO, Qi c/o Enterin, Inc. 2005 Market Street, Suite 3125 Philadelphia, Pennsylvania 19103 / US | 04 /
BRANCATELLI, Giovanna c/o Enterin, Inc. 2005 Market Street, Suite 3125 Philadelphia, Pennsylvania 19103 / US | [2023/04] | Representative(s) | Altmann Stößel Dick Patentanwälte PartG mbB Theodor-Heuss-Anlage 2 68165 Mannheim / DE | [2023/04] | Application number, filing date | 20926164.3 | 25.09.2020 | [2023/04] | WO2020US52608 | Priority number, date | US202062991855P | 19.03.2020 Original published format: US 202062991855 P | [2023/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021188148 | Date: | 23.09.2021 | Language: | EN | [2021/38] | Type: | A1 Application with search report | No.: | EP4121434 | Date: | 25.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.09.2021 takes the place of the publication of the European patent application. | [2023/04] | Search report(s) | International search report - published on: | KR | 23.09.2021 | (Supplementary) European search report - dispatched on: | EP | 22.03.2024 | Classification | IPC: | C07J41/00, A61P25/28, C07F9/09, A61K31/575, A61P9/10, A61K45/06, C07F9/02 | [2024/17] | CPC: |
A61P9/10 (EP);
C07J41/0005 (EP,US);
A61K31/575 (US);
A61K45/06 (EP);
A61P25/28 (EP);
C07F9/02 (EP);
C07B2200/13 (EP,US)
(-)
|
Former IPC [2023/04] | C07F9/09, C07J41/00, A61K31/575, A61P25/28, A61P9/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/04] | Extension states | BA | 14.10.2022 | ME | 14.10.2022 | Title | German: | KRISTALLINE FORMEN VON SQUALAMIN | [2023/04] | English: | CRYSTALLINE FORMS OF SQUALAMINE | [2023/04] | French: | FORMES CRISTALLINES DE SQUALAMINE | [2023/04] | Entry into regional phase | 14.10.2022 | National basic fee paid | 14.10.2022 | Search fee paid | 14.10.2022 | Designation fee(s) paid | 14.10.2022 | Examination fee paid | Examination procedure | 14.10.2022 | Examination requested [2023/04] | 03.05.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 14.10.2022 | Renewal fee patent year 03 | 24.08.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US5721226 (FRYE LEAH L [US], et al) [A] 1-5 * the whole document *; | [A]US2007010504 (CHELLQUIST ERIC [US], et al) [A] 1-5 * the whole document *; | [X]US2011123624 (ZASLOFF MICHAEL [US]) [X] 1-5 * claim 1; paragraphs [0069], [0070], [0184] *; | [X]US2019127416 (BARBUT DENISE [US], et al) [X] 1-5 * abstract; claims 1, 26, 29; paragraphs [0180], [0220], [0221] *; | [A] - CHITKUL, B et al., "A new bio-compatible pH cleavable linker for solid-phase synthesis of a squalamine analogue", Tetrahedron letters, (20010000), vol. 42, no. 35, doi:10.1016/S0040-4039(01)01217-5, pages 6211 - 6214, XP004298218 [A] 1-5 * the whole document * DOI: http://dx.doi.org/10.1016/S0040-4039(01)01217-5 |